study to access the benefit of homoeopathic medicine Apis mellifica 6C in reducing cancer pain

Randomised double blinded placebo controlled study on Apis mellifica 6C in the management of Cancer pain

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/044248

Enrollment

Registered

2022-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G893- Neoplasm related pain (acute) (chronic)

Interventions

Intervention1: Apis Mellifica 6C: daily 1 dose night until symptom changes occurs In homoeopathy Apis Mellifica is obtained as a hydroalcoholic extract of the whole bee assuming, on the basis of the

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Cancer those who are under palliative care

Exclusion criteria

Exclusion criteria: 1 Patients with Psychological disorders 2 Patients with low cognitive functions 3 non-metastatic (early)

Design outcomes

Primary

Measure	Time frame
Assessment of pain using Visual Analogue Scale.Timepoint: Once in two weeks	—

Secondary

Measure	Time frame
Assessment of quality of LifeTimepoint: Once in two weeks.	—

Countries

India

Contacts

Public ContactDr Chandraja C V

Sarada Krishna Homoeopathic Medical College Kulasekharam

sweetpilldoc@gmail.com9843013446

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026